Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 34.49B | 34.67B | 33.34B | 35.98B | 25.30B | 23.22B |
Gross Profit | 6.64B | 6.64B | 5.56B | 5.89B | 5.45B | 3.96B |
EBITDA | 5.36B | 17.83B | 4.81B | 5.00B | 4.69B | 3.12B |
Net Income | 15.13B | 14.53B | 2.78B | 3.18B | 2.76B | 1.68B |
Balance Sheet | ||||||
Total Assets | 116.88B | 116.12B | 76.31B | 56.57B | 51.64B | 51.01B |
Cash, Cash Equivalents and Short-Term Investments | 9.52B | 11.13B | 9.80B | 3.64B | 4.46B | 9.49B |
Total Debt | 13.87B | 17.86B | 11.22B | 2.56B | 1.87B | 2.51B |
Total Liabilities | 39.32B | 43.47B | 24.91B | 14.64B | 13.98B | 15.83B |
Stockholders Equity | 66.88B | 62.06B | 51.40B | 41.92B | 37.66B | 35.17B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.58B | -228.29M | -837.98M | -499.27M | 2.59B |
Operating Cash Flow | 0.00 | 4.98B | 2.20B | 436.88M | 636.01M | 3.43B |
Investing Cash Flow | 0.00 | -4.50B | -3.95B | -1.43B | -4.67B | -1.67B |
Financing Cash Flow | 0.00 | 853.96M | 8.07B | 178.97M | -1.01B | 1.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥60.52B | 4.11 | 1.05% | 3.98% | 430.60% | ||
76 Outperform | ¥49.68B | 13.36 | 4.00% | -4.20% | -20.99% | ||
73 Outperform | ¥52.04B | 13.59 | 6.22% | 12.86% | 41.64% | ||
70 Outperform | ¥42.44B | 8.31 | 4.02% | -1.39% | 16.32% | ||
69 Neutral | ¥55.98B | 15.14 | 2.87% | -8.91% | -27.27% | ||
68 Neutral | ¥47.26B | 19.62 | 4.59% | -9.64% | -31.42% | ||
65 Neutral | $10.77B | 15.80 | 5.51% | 1.90% | 3.03% | -26.66% |